Log In
Print this Print this

Colon PARpanel

  Manage Alerts
Collapse Summary General Information
Company BioMarCare Technologies Ltd.
DescriptionMultiple biomarker blood test for colon cancer based on Protease Activator Receptors (PARs) tumor markers
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose colon cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today